XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2019     189,461          
Beginning balance at Dec. 31, 2019 $ 2,127   $ 0 $ 2,455   $ (353)   $ 25
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued under employee stock plans (in shares)     4,099          
Common stock issued under employee stock plans 152     152        
Taxes paid related to net share settlement of equity awards (509)     (509)        
Stock-based compensation 874     874        
Settlement of 2022 warrants (in shares)     2,285          
Settlement of 2022 notes conversion feature (1,377)     (1,377)        
Benefit from exercise of Note Hedge 1,379     1,379        
Other comprehensive loss, net of tax 69             69
Net income 119         119    
Ending balance (in shares) at Dec. 31, 2020     195,845          
Ending balance at Dec. 31, 2020 $ 2,834   $ 0 2,974   (234)   94
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common stock issued under employee stock plans (in shares) 3,200   3,227          
Common stock issued under employee stock plans $ 168     168        
Taxes paid related to net share settlement of equity awards (612)     (612)        
Stock-based compensation 1,130     1,130        
Settlement of 2022 warrants (in shares)     536          
Settlement of 2022 notes conversion feature (225)     (225)        
Shares granted related to business combination 6     6        
Benefit from exercise of Note Hedge 224     224        
Other comprehensive loss, net of tax (60)             (60)
Net income 230         230    
Ending balance (in shares) at Dec. 31, 2021     199,608          
Ending balance at Dec. 31, 2021 $ 3,695 $ (2) $ 0 3,665 $ (19) (4) $ 17 34
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06              
Common stock issued under employee stock plans (in shares) 2,700   2,671          
Common stock issued under employee stock plans $ 177     177        
Taxes paid related to net share settlement of equity awards (427)     (427)        
Stock-based compensation 1,400     1,400        
Settlement of 2022 warrants (in shares)     603          
Settlement of 2022 notes conversion feature (233)     (233)        
Benefit from exercise of Note Hedge 233     233        
Other comprehensive loss, net of tax (136)             (136)
Net income 325         325    
Ending balance (in shares) at Dec. 31, 2022     202,882          
Ending balance at Dec. 31, 2022 $ 5,032   $ 0 $ 4,796   $ 338   $ (102)